Status:
UNKNOWN
Decision Making in Multiple Sclerosis Care Under Uncertainty
Lead Sponsor:
Unity Health Toronto
Collaborating Sponsors:
Hoffmann-La Roche
University of Toronto
Conditions:
Multiple Sclerosis
Eligibility:
All Genders
23-80 years
Phase:
NA
Brief Summary
The main objectives of this study are: i) To determine patient-level, physician-level and health system factors influencing therapeutic decisions in multiple sclerosis (MS) care by applying conjoint ...
Detailed Description
The landscape of MS care is changing. Currently, there are over 15 disease modifying agents (DMTs) available to treat MS, with varying availability around the world. Significant heterogeneity exists ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Actively practicing neurologist
- Expertise in treating patients with multiple sclerosis (at least 12 per year)
- Clinical setting: academic or community institutions, private practice or outpatient clinic
- Certified physicians in their specialty
- Online consent to participate in the study
Exclusion
Key Trial Info
Start Date :
July 6 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 22 2021
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT04035720
Start Date
July 6 2019
End Date
December 22 2021
Last Update
July 29 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Michael's Hospital
Toronto, Ontario, Canada, M5B 1X2